Clinical Trial Update: Lipoic Acid and Prevention of Heart Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated alpha-lipoic acid for prevention of heart disease in individuals with atherosclerosis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Oregon State University | Conditions: Atherosclerosis | Phase 1 | Status: COMPLETED